An animal study showed that a 4-week treatment with Clostridium butyricum (5 × 108 CFU/day) effectively protected against cognitive impairment and amyloid pathology by reducing microglia-mediated neuroinflammation in an AD (APP/PS1) mouse model [131]. This evidence concerns the gene APP and Cognitive impairment.